These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3324581)

  • 21. Targeting virulence for antimicrobial chemotherapy.
    Lee YM; Almqvist F; Hultgren SJ
    Curr Opin Pharmacol; 2003 Oct; 3(5):513-9. PubMed ID: 14559097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adopting an Anti-virulence (anti-pathogenicity) Approach for Dealing with the Problem of Antimicrobial Resistance.
    Kothari V
    Recent Pat Biotechnol; 2019; 13(4):252-255. PubMed ID: 31724931
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel strategy to target bacterial virulence.
    Baron C
    Future Microbiol; 2013 Jan; 8(1):1-3. PubMed ID: 23252486
    [No Abstract]   [Full Text] [Related]  

  • 25. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
    Scoffone VC; Trespidi G; Chiarelli LR; Barbieri G; Buroni S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
    Chopra I; Hodgson J; Metcalf B; Poste G
    JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacterial infections and ceramide.
    Grassmé H; Becker KA
    Handb Exp Pharmacol; 2013; (216):305-20. PubMed ID: 23563663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionic Modulation of Bacterial Virulence and Its Role in Surgical Infection.
    Alverdy JC
    Surg Infect (Larchmt); 2018; 19(8):769-773. PubMed ID: 30359172
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
    Guillard T; Pons S; Roux D; Pier GB; Skurnik D
    Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic bacteria: how to get them back into the line of fire?
    Keck W; Hubschwerlen C
    Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter to the editor: management of bacterial burden in cattle by TiO2 from grazing.
    McCue JP
    J Dairy Sci; 2004 Jun; 87(6):1579. PubMed ID: 15453469
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions between the microbiota and pathogenic bacteria in the gut.
    Bäumler AJ; Sperandio V
    Nature; 2016 Jul; 535(7610):85-93. PubMed ID: 27383983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can resistance against quorum-sensing interference be selected?
    García-Contreras R; Maeda T; Wood TK
    ISME J; 2016 Jan; 10(1):4-10. PubMed ID: 26023871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
    Totsika M
    Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
    [No Abstract]   [Full Text] [Related]  

  • 35. Oxidative stress and antibiotic resistance in bacterial pathogens: state of the art, methodologies, and future trends.
    Marrakchi M; Liu X; Andreescu S
    Adv Exp Med Biol; 2014; 806():483-98. PubMed ID: 24952198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.
    Rampioni G; Leoni L; Williams P
    Bioorg Chem; 2014 Aug; 55():60-8. PubMed ID: 24823895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fighting the enemy within.
    Tacconelli E; Autenrieth IB; Peschel A
    Science; 2017 Feb; 355(6326):689-690. PubMed ID: 28209857
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of macrolides on the expression of bacterial virulence mechanisms.
    Shryock TR; Mortensen JE; Baumholtz M
    J Antimicrob Chemother; 1998 May; 41(5):505-12. PubMed ID: 9630404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance in bacteria.
    Amyes SG; Gemmell CG
    J Med Microbiol; 1992 Jan; 36(1):4-29. PubMed ID: 1731057
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic resistance: the pandemic.
    Verhoef J
    Adv Exp Med Biol; 2003; 531():301-13. PubMed ID: 12916802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.